News
The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...
The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.
The agency gave a name to the artificial intelligence program it’s been developing to support safety profile assessments, ...
The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...
The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.
The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results